ORAL AND PARENTERAL THERAPY WITH SAPERCONAZOLE (R-66905) OF INVASIVE ASPERGILLOSIS IN NORMAL AND IMMUNOCOMPROMISED ANIMALS

被引：32

作者：

VANCUTSEM, J

VANGERVEN, F

JANSSEN, PAJ

机构：

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1989年 / 33卷 / 12期

关键词：

D O I：

10.1128/AAC.33.12.2063

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：2063 / 2068

页数：6

共 19 条

[1] INVASIVE ASPERGILLOSIS IN ACUTE-LEUKEMIA - CORRELATION WITH NOSE CULTURES AND ANTIBIOTIC USE [J].

AISNER, J ;

MURILLO, J ;

SCHIMPFF, SC ;

STEERE, AC .

ANNALS OF INTERNAL MEDICINE, 1979, 90 (01) :4-9

[2]

Cauwenbergh G, 1988, Ann N Y Acad Sci, V544, P264, DOI 10.1111/j.1749-6632.1988.tb40412.x

[3]

Cutsem J. van, 1987, Recent trends in the discovery, development and evaluation of antifungal agents., P177

[4] INVITRO STUDIES WITH R-51,211 (ITRACONAZOLE) [J].

ESPINELINGROFF, A ;

SHADOMY, S ;

GEBHART, RJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (01) :5-9

[5]

GRAYBILL JR, 1985, SABOURAUDIA, V23, P219

[6] ANTIMYCOTIC AZOLES .7. SYNTHESIS AND ANTIFUNGAL PROPERTIES OF A SERIES OF NOVEL TRIAZOL-3-ONES [J].

HEERES, J ;

BACKX, LJJ ;

VANCUTSEM, J .

JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (07) :894-900

[7] ANTIFUNGAL RELATIVE INHIBITION FACTORS - BAY 1-9139, BIFONAZOLE, BUTOCONAZOLE, ISOCONAZOLE, ITRACONAZOLE (R-51211), OXICONAZOLE, RO-14-4767/002, SULCONAZOLE, TERCONAZOLE AND VIBUNAZOLE (BAY N-7133) COMPARED INVITRO WITH 9 ESTABLISHED ANTIFUNGAL AGENTS [J].

ODDS, FC ;

WEBSTER, CE ;

ABBOTT, AB .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 14 (02) :105-114

[8] ASPERGILLUS PNEUMONIA IN HEMATOLOGIC MALIGNANCY - IMPROVEMENTS IN DIAGNOSIS AND THERAPY [J].

PENNINGTON, JE .

ARCHIVES OF INTERNAL MEDICINE, 1977, 137 (06) :769-771

[9]

SAAG MS, 1988, ANTIMICROB AGENTS CH, V32, P1, DOI 10.1128/AAC.32.1.1

[10] PRECLINICAL ANIMAL STUDY MODELS FOR ANTIFUNGAL DRUGS [J].

VANCUTSEM, J ;

JANSSEN, PAJ .

MEDECINE ET MALADIES INFECTIEUSES, 1987, 17 (8-9) :428-435

← 1 2 →